Pregnancy and pituitary disorders

European Journal of Endocrinology

Volumn 162, Issue 3, 2010, Pages 453-475

  Karaca, Z ^a   Tanriverdi, F ^a   Unluhizarci, K ^a   Kelestimur, F ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOHYPOPHYSIS HORMONE; BROMOCRIPTINE; GONADOTROPIN; GROWTH HORMONE; OCTREOTIDE; PEGVISOMANT; PROLACTIN; PROTIRELIN; SOMATOMEDIN C; THYROTROPIN;

ACROMEGALY; CRANIOPHARYNGIOMA; CUSHING DISEASE; HORMONE RELEASE; HUMAN; HYPOPHYSIS; HYPOPHYSIS ADENOMA; HYPOPHYSIS DISEASE; HYPOPHYSIS FUNCTION; HYPOPITUITARISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NEUROHYPOPHYSIS; PREGNANCY; PRIORITY JOURNAL; PROLACTINOMA; REVIEW; THYROTROPIN SECRETING ADENOMA; TUMOR GROWTH;

FEMALE; HUMANS; PITUITARY DISEASES; PITUITARY GLAND; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 77149179359     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0923     Document Type: Review

References (293)

1. Melmed S & Kleinberg D. Anterior pituitary. In Williams Textbook of Endocrinology, edn 10, ch 8, pp 177-279. Eds PR Larsen, HM Kronenberg, S Melmed & KS Polonsky. Philadelphia, PA: Saunders, 2003.
2. Amar AP & Weiss MH. Pituitary anatomy and physiology. Neurosurgery Clinics of North America 2003 14 11-23.
3. Elster AD. Modern imaging of the pituitary. Radiology 1993 187 1-14.
4. Comte L. Contribution a l'etude de l'hypophse humaine. Doctoral Thesis 1898. Switzerland: Lausanne.
5. Goluboff LG & Ezrin C. Effect of pregnancy on the somatotroph and the prolactin cell of the human adenohypophysis. Journal of Clinical Endocrinology and Metabolism 1969 29 1533-1538.
6. Scheithauer BW, Sano T, Kovacs KT, Young WF Jr, Ryan N & Randall RV. The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 cases. Mayo Clinic Proceedings 1990 65 461-474.
7. Gonzalez JG, Elizondo G, Saldivar D, Nanez H, Todd LE & Villarreal JZ. Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. American Journal of Medicine 1988 85 217-220.
8. Dinc H, Esen F, Demirci A, Sari A & Resit GH. Pituitary dimensions and volume measurements in pregnancy and post partum. MR assessment. Acta Radiologica 1998 39 64-69.
9. Elster AD, Sanders TG, Vines FS & Chen MY. Size and shape of the pituitary gland during pregnancy and post partum: measurement with MR imaging. Radiology 1991 181 531-535.
10. Wolpert SM, Molitch ME, Goldman JA & Wood JB. Size, shape, and appearance of the normal female pituitary gland. American Journal of Roentgenology 1984 143 377-381.
11. Chen HW, Su DH, Chen HW, Yang CH & Chang CC. Abnormal enlargement of pituitary gland during pregnancy remitted spontaneously after delivery. Chang Gung Medical Journal 2007 30 81-86.
12. Heald AH, Hughes D, King A & Buckler H. Pregnancy related pituitary enlargement mimicking macroadenoma. British Journal of Neurosurgery 2004 18 524-526.
13. Inoue T, Hotta A, Awai M & Tanihara H. Loss of vision due to a physiologic pituitary enlargement during normal pregnancy. Graefe's Archive for Clinical and Experimental Ophthalmology 2007 245 1049-1051.
14. Kanal E, Barkovich AJ, Bell C, Borgstede JP, Bradley WG Jr, Froelich JW, Gilk T, Gimbel JR, Gosbee J, Kuhni-Kaminski E, Lester JW Jr, Nyenhuis J, Parag Y, Schaefer DJ, Sebek-Scoumis EA, Weinreb J, Zaremba LA, Wilcox P, Lucey L & Sass N. ACR guidance document for safe MR practices. American Journal of Roentgenology 2007 188 1447-1474.
15. Lin SP & Brown JJ. MR contrast agents: physical and pharmacologic basics. Journal of Magnetic Resonance Imaging 2007 25 884-899.
16. Barkhof F, Heijboer RJ & Algra PR. Inadvertent i.v. administration of gadopentetate dimeglumine during early pregnancy. American Journal of Roentgenology 1992 158 1171.
17. Birchard KR, Brown MA, Hyslop WB, Firat Z & Semelka RC. MRI of acute abdominal and pelvic pain in pregnant patients. American Journal of Roentgenology 2005 184 452-458.
18. Marcos HB, Semelka RC & Worawattanakul S. Normal placenta: gadolinium-enhanced dynamic MR imaging. Radiology 1997 205 493-496.
19. Shoenut JP, Semelka RC, Silverman R, Yaffe CS & Micflikier AB. MRI in the diagnosis of Crohn's disease in two pregnant women. Journal of Clinical Gastroenterology 1993 17 244-247.
20. Carr BR, Parker CR Jr, Madden JD, MacDonald PC & Porter JC. Maternal plasma adrenocorticotropin and cortisol relationships throughout human pregnancy. American Journal of Obstetrics and Gynecology 1981 139 416-422.
21. Nolten WE, Lindheimer MD, Rueckert PA, Oparil S & Ehrlich EN. Diurnal patterns and regulation of cortisol secretion in pregnancy. Journal of Clinical Endocrinology and Metabolism 1980 51 466-472.
22. Scott EM, McGarrigle HH & Lachelin GC. The increase in plasma and saliva cortisol levels in pregnancy is not due to the increase in corticosteroid-binding globulin levels. Journal of Clinical Endocrinology and Metabolism 1990 71 639-644.
23. Demey-Ponsart E, Foidart JM, Sulon J & Sodoyez JC. Serum CBG, free and total cortisol and circadian patterns of adrenal function in normal pregnancy. Journal of Steroid Biochemistry 1982 16 165-169.
24. Allolio B, Hoffmann J, Linton EA, Winkelmann W, Kusche M & Schulte HM. Diurnal salivary cortisol patterns during pregnancy and after delivery relationship to plasma corticotrophin-releasing-hormone. Clinical Endocrinology 1990 33 279-289.
25. Cousins L, Rigg L, Hollingsworth D, Meis P, Halberg F, Brink G & Yen SS. Qualitative and quantitative assessment of the circadian rhythm of cortisol in pregnancy. American Journal of Obstetrics and Gynecology 1983 145 411-416.
26. Magiakou MA, Mastorakos G, Rabin D, Margioris AN, Dubbert B, Calogero AE, Tsigos C, Munson PJ & Chrousos GP. The maternal hypothalamic-pituitary- adrenal axis in the third trimester of human pregnancy. Clinical Endocrinology 1996 44 419-428.
27. Mukherjee K & Swyer GI. Plasma cortisol and adrenocorticotrophic hormone in normal men and non-pregnant women, normal pregnant women and women with pre-eclampsia. Journal of Obstetrics and Gynaecology of the British Commonwealth 1972 79 504-512.
28. Lindsay JR & Nieman LK. The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment. Endocrine Reviews 2005 26 775-799.
29. Seckl JR, Cleasby M & Nyirenda MJ. Glucocorticoids, 11bhydroxysteroid dehydrogenase, and fetal programming. Kidney International 2000 57 1412-1417.
30. Murphy BE. Conversion of cortisol to cortisone by the human uterus and its reversal in pregnancy. Journal of Clinical Endocrinology and Metabolism 1977 44 1214-1217.
31. Atkinson HC & Waddell BJ. The hypothalamic-pituitary-adrenal axis in rat pregnancy and lactation: circadian variation and interrelationship of plasma adrenocorticotropin and corticosterone. Endocrinology 1995 136 512-520.
32. Demura R, Odagiri E, Yoshimura M, Jibiki K, Adachi T, Shirota M, Demura H, Shizume K & Oouchi H. Placental secretion of prolactin, ACTH and immunoreactive beta-endorphin during pregnancy. Acta Endocrinologica 1982 100 114-119.
33. Petraglia F, Sawchenko PE, Rivier J & Vale W. Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature 1987 328 717-719.
34. Fadalti M, Pezzani I, Cobellis L, Springolo F, Petrovec MM, Ambrosini G, Reis FM & Petraglia F. Placental corticotropinreleasing factor. An update. Annals of the New York Academy of Sciences 2000 900 89-94.
35. Blumenfeld Z & Jaffe RB. Hypophysiotropic and neuromodulatory regulation of adrenocorticotropin in the human fetal pituitary gland. Journal of Clinical Investigation 1986 78 288-294.
36. Robinson BG, Emanuel RL, Frim DM & Majzoub JA. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. PNAS 1988 85 5244-5248.
37. Sasaki A, Shinkawa O & Yoshinaga K. Placental corticotropinreleasing hormone may be a stimulator of maternal pituitary adrenocorticotropic hormone secretion in humans. Journal of Clinical Investigation 1989 84 1997-2001.
38. Hobel CJ, Arora CP & Korst LM. Corticotrophin-releasing hormone and CRH-binding protein. Differences between patients at risk for preterm birth and hypertension. Annals of the New York Academy of Sciences 1999 897 54-65.
39. Sehringer B, Zahradnik HP, Simon M, Ziegler R, Noethling C & Schaefer WR. mRNA expression profiles for corticotrophinreleasing hormone, urocortin, CRH-binding protein and CRH receptors in human term gestational tissues determined by realtime quantitative RT-PCR. Journal of Molecular Endocrinology 2004 32 339-348.
40. Kalantaridou SN, Makrigiannakis A, Mastorakos G & Chrousos GP. Roles of reproductive corticotropin-releasing hormone. Annals of the New York Academy of Sciences 2003 997 129-135.
41. Verhaeghe J. Does the physiological acromegaly of pregnancy benefit the fetus? Gynecologic and Obstetric Investigation 2008 66 217-226.
42. El Kasti MM, Christian HC, Huerta-Ocampo I, Stolbrink M, Gill S, Houston PA, Davies JS, Chilcott J, Hill N, Matthews DR, Carter DA & Wells T. The pregnancy-induced increase in baseline circulating growth hormone in rats is not induced by ghrelin. Journal of Neuroendocrinology 2008 20 309-322.
43. Chellakooty M, Vangsgaard K, Larsen T, Scheike T, Falck-Larsen J, Legarth J, Andersson AM, Main KM, Skakkebaek NE & Juul A. A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor 1 axis in maternal circulation: association between placental GH and fetal growth. Journal of Clinical Endocrinology and Metabolism 2004 89 384-391.
44. Fuglsang J, Sandager P, Moller N, Fisker S, Frystyk J & Ovesen P. Peripartum maternal and foetal ghrelin, growth hormones, IGFs and insulin interrelations. Clinical Endocrinology 2006 64 502-509.
45. Igout A, Frankenne F, L'Hermite-Baleriaux M, Martin A & Hennen G. Somatogenic and lactogenic activity of the recombinant 22 kDa isoform of human placental growth hormone. Growth Regulation 1995 5 60-65.
46. Eriksson L, Frankenne F, Eden S, Hennen G & Von Schoultz B. Growth hormone 24-h serum profiles during pregnancy - lack of pulsatility for the secretion of the placental variant. British Journal of Obstetrics and Gynaecology 1989 96 949-953.
47. Frankenne F, Closset J, Gomez F, Scippo ML, Smal J & Hennen G. The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant. Journal of Clinical Endocrinology and Metabolism 1988 66 1171-1180.
48. de Zegher F, Vanderschueren-Lodeweyckx M, Spitz B, Faijerson Y, Blomberg F, Beckers A, Hennen G & Frankenne F. Perinatal growth hormone (GH) physiology: effect of GH-releasing factor on maternal and fetal secretion of pituitary and placental GH. Journal of Clinical Endocrinology and Metabolism 1990 71 520-522.
49. Samaan NA, Goplerud CP & Bradbury JT. Effect of arginine infusion on plasma levels of growth hormone, insulin, and glucose during pregnancy and the puerperium. American Journal of Obstetrics and Gynecology 1970 107 1002-1007.
50. Yen SS, Vela P & Tsai CC. Impairment of growth hormone secretion in response to hypoglycemia during early and late pregnancy. Journal of Clinical Endocrinology and Metabolism 1970 31 29-32.
51. Rigg LA, Lein A & Yen SS. Pattern of increase in circulating prolactin levels during human gestation. American Journal of Obstetrics and Gynecology 1977 129 454-456.
52. Bohnet HG, Naber NG, del Pozo E & Schneider HP. Effects of synthetic gestagens on serum prolactin and growth hormone secretion in amenorrheic patients. Archives of Gynecology 1978 226 233-240.
53. Riddick DH, Luciano AA, Kusmik WF & Maslar IA. Evidence for a nonpituitary source of amniotic fluid prolactin. Fertility and Sterility 1979 31 35-39.
54. Foyouzi N, Frisbaek Y & Norwitz ER. Pituitary gland and pregnancy. Obstetrics and Gynecology Clinics of North America 2004 31 873-892 (xi).
55. Kwa HG, Cleton F, Bulbrook RD,Wang DY & Hayward JL. Plasma prolactin levels and breast cancer: relation to parity, weight and height, and age at first birth. International Journal of Cancer 1981 28 31-34.
56. Yu MC, Gerkins VR, Henderson BE, Brown JB & Pike MC. Elevated levels of prolactin in nulliparous women. British Journal of Cancer 1981 43 826-831.
57. Farkouh NH, Packer MG & Frantz AG. Large molecular size prolactin with reduced receptor activity in human serum: high proportion in basal state and reduction after thyrotropinreleasing hormone. Journal of Clinical Endocrinology and Metabolism 1979 48 1026-1032.
58. Pansini F, Bergamini CM, Malfaccini M, Cocilovo G, Linciano M, Jacobs M & Bagni B. Multiple molecular forms of prolactin during pregnancy in women. Journal of Endocrinology 1985 106 81-85.
59. Suh HK & Frantz AG. Size heterogeneity of human prolactin in plasma and pituitary extracts. Journal of Clinical Endocrinology and Metabolism 1974 39 928-935.
60. Hattori N. The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies. Journal of Clinical Endocrinology and Metabolism 1996 81 586-590.
61. Pascoe-Lira D, Duran-Reyes G, Contreras-Hernandez I, Manuel-Apolinar L, Blanco-Favela F & Leanos-Miranda A. Frequency of macroprolactinemia due to autoantibodies against prolactin in pregnant women. Journal of Clinical Endocrinology and Metabolism 2001 86 924-929.
62. Leanos-Miranda A, Pascoe-Lira D, Chavez-Rueda KA & Blanco-Favela F. Persistence of macroprolactinemia due to antiprolactin autoantibody before, during, and after pregnancy in a woman with systemic lupus erythematosus. Journal of Clinical Endocrinology and Metabolism 2001 86 2619-2624.
63. Glinoer D, de Nayer P, Bourdoux P, Lemone M, Robyn C, van Steirteghem A, Kinthaert J & Lejeune B. Regulation of maternal thyroid during pregnancy. Journal of Clinical Endocrinology and Metabolism 1990 71 276-287.
64. Burrow GN, Fisher DA & Larsen PR. Maternal and fetal thyroid function. New England Journal of Medicine 1994 331 1072-1078.
65. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocrine Reviews 1997 18 404-433.
66. Roti E, Gardini E, Minelli R, Bianconi L & Flisi M. Thyroid function evaluation by different commercially available free thyroid hormone measurement kits in term pregnant women and their newborns. Journal of Endocrinological Investigation 1991 14 1-9.
67. Guillaume J, Schussler GC & Goldman J. Components of the total serum thyroid hormone concentrations during pregnancy: high free thyroxine and blunted thyrotropin (TSH) response to TSHreleasing hormone in the first trimester. Journal of Clinical Endocrinology and Metabolism 1985 60 678-684.
68. Weeke J, Dybkjaer L, Granlie K, Eskjaer JS, Kjaerulff E, Laurberg P & Magnusson B. A longitudinal study of serum TSH, and total and free iodothyronines during normal pregnancy. Acta Endocrinologica 1982 101 531-537.
69. Mandel SJ, Larsen PR, Seely EW & Brent GA. Increased need for thyroxine during pregnancy in women with primary hypothyroidism. New England Journal of Medicine 1990 323 91-96.
70. Reyes FI, Winter JS & Faiman C. Pituitary gonadotropin function during human pregnancy: serum FSH and LH levels before and after LHRH administration. Journal of Clinical Endocrinology and Metabolism 1976 42 590-592.
71. Davison JM, Vallotton MB & Lindheimer MD. Plasma osmolality and urinary concentration and dilution during and after pregnancy: evidence that lateral recumbency inhibits maximal urinary concentrating ability. British Journal of Obstetrics and Gynaecology 1981 88 472-479.
72. Shehata HA & Okosun H. Neurological disorders in pregnancy. Current Opinion in Obstetrics and Gynecology 2004 16 117-122.
73. Hime MC & Richardson JA. Diabetes insipidus and pregnancy. Case report, incidence and review of literature. Obstetrical and Gynecological Survey 1978 33 375-379.
74. Lado-Abeal J, Rodriguez-Arnao J, Newell-Price JD, Perry LA, Grossman AB, Besser GM & Trainer PJ. Menstrual abnormalities in women with Cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels. Journal of Clinical Endocrinology and Metabolism 1998 83 3083-3088.
75. Yamaji T, Ishibashi M, Teramoto A & Fukushima T. Hyperprolactinemia in Cushing's disease and Nelson's syndrome. Journal of Clinical Endocrinology and Metabolism 1984 58 790-795.
76. Guilhaume B, Sanson ML, Billaud L, Bertagna X, Laudat MH & Luton JP. Cushing's syndrome and pregnancy: aetiologies and prognosis in twenty-two patients. European Journal of Medicine 1992 1 83-89.
77. Lubin V, Gautier JF, Antoine JM, Beressi JP & Vexiau P. Cushing's syndrome during pregnancy. Presse Médicale 2002 31 1706-1713.
78. Miyoshi T, Otsuka F, Suzuki J, Inagaki K, Takeda M, Kano Y, Yamashita T, Ogura T, Date I, Tanaka Y, Hashimoto K & Makino H. Periodic secretion of adrenocorticotropin in a patient with Cushing's disease manifested during pregnancy. Endocrine Journal 2005 52 287-292.
79. Chico A, Manzanares JM, Halperin I, Martinez de Osaba MJ, Adelantado J & Webb SM. Cushing's disease and pregnancy: report of six cases. European Journal of Obstetrics, Gynecology, and Reproductive Biology 1996 64 143-146.
80. Sheeler LR. Cushing's syndrome and pregnancy. Endocrinology and Metabolism Clinics of North America 1994 23 619-627.
81. Prebtani AP, Donat D & Ezzat S. Worrisome striae in pregnancy. Lancet 2000 355 1692.
82. Tajika T, Shinozaki T, Watanabe H, Yangawa T & Takagishi K. Case report of a Cushing's syndrome patient with multiple pathologic fractures during pregnancy. Journal of Orthopaedic Science 2002 7 498-500.
83. Odagiri E, Ishiwatari N, Abe Y, Jibiki K, Adachi T, Demura R, Demura H & Shizume K. Hypercortisolism and the resistance to dexamethasone suppression during gestation. Endocrinologia Japonica 1988 35 685-690.
84. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM& Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 1526-1540.
85. Polli N, Pecori GF & Cavagnini F. Cushing's disease and pregnancy. Pituitary 2004 7 237-241.
86. Schulte HM, Weisner D & Allolio B. The corticotrophin releasing hormone test in late pregnancy: lack of adrenocorticotrophin and cortisol response. Clinical Endocrinology 1990 33 99-106.
87. Suda T, Iwashita M, Ushiyama T, Tozawa F, Sumitomo T, Nakagami Y, Demura H & Shizume K. Responses to corticotropinreleasing hormone and its bound and free forms in pregnant and nonpregnant women. Journal of Clinical Endocrinology and Metabolism 1989 69 38-42.
88. Mellor A, Harvey RD, Pobereskin LH & Sneyd JR. Cushing's disease treated by trans-sphenoidal selective adenomectomy in mid-pregnancy. British Journal of Anaesthesia 1998 80 850-852.
89. Coyne TJ, Atkinson RL & Prins JB. Adrenocorticotropic hormonesecreting pituitary tumor associated with pregnancy: case report. Neurosurgery 1992 31 953-955.
90. Pinette MG, Pan YQ, Oppenheim D, Pinette SG & Blackstone J. Bilateral inferior petrosal sinus corticotropin sampling with corticotropin-releasing hormone stimulation in a pregnant patient with Cushing's syndrome. American Journal of Obstetrics and Gynecology 1994 171 563-564.
91. Buescher MA, McClamrock HD & Adashi EY. Cushing syndrome in pregnancy. Obstetrics and Gynecology 1992 79 130-137.
92. Casson IF, Davis JC, Jeffreys RV, Silas JH,Williams J & Belchetz PE. Successful management of Cushing's disease during pregnancy by transsphenoidal adenectomy. Clinical Endocrinology 1987 27 423-428.
93. Bevan JS, Othman S, Lazarus JH, Parkes AB & Hall R. Reversible adrenocorticotropin deficiency due to probable autoimmune hypophysitis in a woman with postpartum thyroiditis. Journal of Clinical Endocrinology and Metabolism 1992 74 548-552.
94. Verdugo C, Donoso J, Meza H, Domke G, Esterio H, Martinez A & Cruz G. Cushing's syndrome and pregnancy with spontaneous remission after delivery. Revista Médica de Chile 1982 110 564-569.
95. Chiodini I, Losa M, Pavone G, Trischittal V & Scillitani A. Pregnancy in Cushing's disease shortly after treatment by gamma-knife radiosurgery. Journal of Endocrinological Investigation 2004 27 954-956.
96. Amado JA, Pesquera C, Gonzalez EM, Otero M, Freijanes J & Alvarez A. Successful treatment with ketoconazole of Cushing's syndrome in pregnancy. Postgraduate Medical Journal 1990 66 221-223.
97. Berwaerts J, Verhelst J, Mahler C & Abs R. Cushing's syndrome in pregnancy treated by ketoconazole: case report and review of the literature. Gynecological Endocrinology 1999 13 175-182.
98. Sonino N. The use of ketoconazole as an inhibitor of steroid production. New England Journal of Medicine 1987 317 812-818.
99. Cabezon C, Bruno OD, Cohen M, Garcia S & Gutman RA. Twin pregnancy in a patient with Cushing's disease. Fertility and Sterility 1999 72 371-372.
100. Close CF, Mann MC, Watts JF & Taylor KG. ACTH-independent Cushing's syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone. Clinical Endocrinology 1993 39 375-379.
101. Connell JM, Cordiner J, Davies DL, Fraser R, Frier BM & McPherson SG. Pregnancy complicated by Cushing's syndrome: potential hazard of metyrapone therapy. Case report. British Journal of Obstetrics and Gynaecology 1985 92 1192-1195.
102. Gormley MJ, Hadden DR, Kennedy TL, Montgomery DA, Murnaghan GA & Sheridan B. Cushing's syndrome in pregnancy - treatment with metyrapone. Clinical Endocrinology 1982 16 283-293.
103. Hana V, Dokoupilova M, Marek J & Plavka R. Recurrent ACTHindependent Cushing's syndrome in multiple pregnancies and its treatment with metyrapone. Clinical Endocrinology 2001 54 277-281.
104. Wallace C, Toth EL, Lewanczuk RZ & Siminoski K. Pregnancyinduced Cushing's syndrome in multiple pregnancies. Journal of Clinical Endocrinology and Metabolism 1996 81 15-21.
105. Leiba S, Weinstein R, Shindel B, Lapidot M, Stern E, Levavi H, Rusecki Y & Abramovici A. The protracted effect of o,p0-DDD in Cushing's disease and its impact on adrenal morphogenesis of young human embryo. Annales d'Endocrinologie 1989 50 49-53.
106. Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S, Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JA & Boscaro M. Treatment of adrenocorticotropindependent Cushing's syndrome: a consensus statement. Journal of Clinical Endocrinology and Metabolism 2008 93 2454-2462.
107. Sauder SE, Frager M, Case GD, Kelch RP & Marshall JC. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine. Journal of Clinical Endocrinology and Metabolism 1984 59 941-948.
108. Herman-Bonert V, Seliverstov M & Melmed S. Pregnancy in acromegaly: successful therapeutic outcome. Journal of Clinical Endocrinology and Metabolism 1998 83 727-731.
109. Unal A, Sahin Y & Kelestimur F. Acromegaly with polycystic ovaries, hyperandrogenism, hirsutism, insulin resistance and acanthosis nigricans: a case report. Endocrine Journal 1993 40 207-211.
110. Beckers A, Stevenaert A, Foidart JM, Hennen G & Frankenne F. Placental and pituitary growth hormone secretion during pregnancy in acromegalic women. Journal of Clinical Endocrinology and Metabolism 1990 71 725-731.
111. Hisano M, Sakata M, Watanabe N, Kitagawa M, Murashima A & Yamaguchi K. An acromegalic woman first diagnosed in pregnancy. Archives of Gynecology and Obstetrics 2006 274 171-173.
112. Mozas J, Ocon E, de La Torre ML, Suarez AM, Miranda JA & Herruzo AJ. Successful pregnancy in a woman with acromegaly treated with somatostatin analog (octreotide) prior to surgical resection. International Journal of Gynaecology and Obstetrics 1999 65 71-73.
113. Chang-DeMoranville BM & Jackson IM. Diagnosis and endocrine testing in acromegaly. Endocrinology and Metabolism Clinics of North America 1992 21 649-668.
114. Barkan AL, Stred SE, Reno K, Markovs M, Hopwood NJ, Kelch RP & Beitins IZ. Increased growth hormone pulse frequency in acromegaly. Journal of Clinical Endocrinology and Metabolism 1989 69 1225-1233.
115. Newman CB. Medical therapy for acromegaly. Endocrinology and Metabolism Clinics of North America 1999 28 171-190.
116. Jaspers C, Haase R, Pfingsten H, Benker G & Reinwein D. Long-term treatment of acromegalic patients with repeatable parenteral depot-bromocriptine. Clinical Investigator 1993 71 547-551.
117. Miyakawa I, Taniyama K, Koike H, Mori N, Nagamine M, Kuribayashi T & Araki S. Successful pregnancy in an acromegalic patient during 2-Br-alpha-ergocryptine (CB-154) therapy. Acta Endocrinologica 1982 101 333-338.
118. Yap AS, Clouston WM, Mortimer RH & Drake RF. Acromegaly first diagnosed in pregnancy: the role of bromocriptine therapy. American Journal of Obstetrics and Gynecology 1990 163 477-478.
119. Blackhurst G, Strachan MW, Collie D, Gregor A, Statham PF & Seckl JE. The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy. Clinical Endocrinology 2002 57 401-404.
120. Boulanger C, Vezzosi D, Bennet A, Lorenzini F, Fauvel J & Caron P. Normal pregnancy in a woman with nesidioblastosis treated with somatostatin analog octreotide. Journal of Endocrinological Investigation 2004 27 465-470.
121. Fassnacht M, Capeller B, Arlt W, Steck T & Allolio B. Octreotide LAR treatment throughout pregnancy in an acromegalic woman. Clinical Endocrinology 2001 55 411-415.
122. Neal JM. Successful pregnancy in a woman with acromegaly treated with octreotide. Endocrine Practice 2000 6 148-150.
123. Caron P, Buscail L, Beckers A, Esteve JP, Igout A, Hennen G & Susini C. Expression of somatostatin receptor SST4 in human placenta and absence of octreotide effect on human placental growth hormone concentration during pregnancy. Journal of Clinical Endocrinology and Metabolism 1997 82 3771-3776.
124. Takano T, Saito J, Soyama A, Ito H, Iizuka T, Yoshida T & Nishikawa T. Normal delivery following an uneventful pregnancy in a Japanese acromegalic patient after discontinuation of octreotide long acting release formulation at an early phase of pregnancy. Endocrine Journal 2006 53 209-212.
125. Caron P, Gerbeau C & Pradayrol L. Maternal-fetal transfer of octreotide. New England Journal of Medicine 1995 333 601-602.
126. de Menis E, Billeci D, Marton E & Gussoni G. Uneventful pregnancy in an acromegalic patient treated with slow-release lanreotide a case report. Journal of Clinical Endocrinology and Metabolism 1999 84 1489.
127. Brian SR, Bidlingmaier M, Wajnrajch MP, Weinzimer SA & Inzucchi SE. Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects. Journal of Clinical Endocrinology and Metabolism 2007 92 3374-3377.
128. Qureshi A, Kalu E, Ramanathan G, Bano G, Croucher C & Panahloo A. IVF/ICSI in a woman with active acromegaly: successful outcome following treatment with pegvisomant. Journal of Assisted Reproduction and Genetics 2006 23 439-442.
129. Molitch ME. Pituitary disorders during pregnancy. Endocrinology and Metabolism Clinics of North America 2006 35 99-116.
130. Lau SL, McGrath S, Evain-Brion D & Smith R. Clinical and biochemical improvement in acromegaly during pregnancy. Journal of Endocrinological Investigation 2008 31 255-261.
131. Atmaca A, Dagdelen S & Erbas T. Follow-up of pregnancy in acromegalic women: different presentations and outcomes. Experimental and Clinical Endocrinology and Diabetes 2006 114 135-139.
132. Colao A, Merola B, Ferone D & Lombardi G. Acromegaly. Journal of Clinical Endocrinology and Metabolism 1997 82 2777-2781.
133. Cozzi R, Attanasio R & Barausse M. Pregnancy in acromegaly: a one-center experience. European Journal of Endocrinology 2006 155 279-284.
134. Arafah BM & Nasrallah MP. Pituitary tumors: pathophysiology, clinical manifestations and management. Endocrine-Related Cancer 2001 8 287-305.
135. Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD, Brue T, Cappabianca P, Colao A, Fahlbusch R, Fideleff H, Hadani M, Kelly P, Kleinberg D, Laws E, Marek J, Scanlon M, Sobrinho LG,Wass JA & Giustina A. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clinical Endocrinology 2006 65 265-273.
136. Molitch ME. Pregnancy and the hyperprolactinemic woman. New England Journal of Medicine 1985 312 1364-1370.
137. Musolino NRC & Bronstein MD. Prolactinomas pregnancy. In Pituitary Tumors in Pregnancy, pp 91-108. Ed. MD Bronstein, Boston: Kluwer Academic Publishers, 2001.
138. Heaney AP, Fernando M & Melmed S. Functional role of estrogen in pituitary tumor pathogenesis. Journal of Clinical Investigation 2002 109 277-283.
139. Ciccarelli E & Camanni F. Diagnosis and drug therapy of prolactinoma. Drugs 1996 51 954-965.
140. Crosignani PG. Current treatment issues in female hyperprolactinaemia. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2006 125 152-164.
141. Bronstein MD, Salgado LR & Castro Musolino NR. Medical management of pituitary adenomas: the special case of management of the pregnant woman. Pituitary 2002 5 99-107.
142. Holmgren U, Bergstrand G, Hagenfeldt K & Werner S. Women with prolactinoma - effect of pregnancy and lactation on serum prolactin and on tumour growth. Acta Endocrinologica 1986 111 452-459.
143. Kupersmith MJ, Rosenberg C & Kleinberg D. Visual loss in pregnant women with pituitary adenomas. Annals of Internal Medicine 1994 121 473-477.
144. Molitch ME. Management of prolactinomas during pregnancy. Journal of Reproductive Medicine 1999 44 1121-1126.
145. Brodsky JB, Cohen EN, Brown BW Jr, Wu ML & Whitcher C. Surgery during pregnancy and fetal outcome. American Journal of Obstetrics and Gynecology 1980 138 1165-1167.
146. Griffith RW, Turkalj I & Braun P. Outcome of pregnancy in mothers given bromocriptine. British Journal of Clinical Pharmacology 1978 5 227-231.
147. Konopka P, Raymond JP, Merceron RE & Seneze J. Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas. American Journal of Obstetrics and Gynecology 1983 146 935-938.
148. Krupp P & Monka C. Bromocriptine in pregnancy: safety aspects. Klinische Wochenschrift 1987 65 823-827.
149. Turkalj I, Braun P & Krupp P. Surveillance of bromocriptine in pregnancy. Journal of the American Medical Association 1982 247 1589-1591.
150. Raymond JP, Goldstein E, Konopka P, Leleu MF, Merceron RE & Loria Y. Follow-up of children born of bromocriptine-treated mothers. Hormone Research 1985 22 239-246.
151. Sam S & Molitch ME. Timing and special concerns regarding endocrine surgery during pregnancy. Endocrinology and Metabolism Clinics of North America 2003 32 337-354.
152. Chiodini I & Liuzzi A. PRL-secreting pituitary adenomas in pregnancy. Journal of Endocrinological Investigation 2003 26 96-99.
153. Colao A, Abs R, Barcena DG, Chanson P, Paulus W & Kleinberg DL. Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study. Clinical Endocrinology 2008 68 66-71.
154. Jones J, Bashir T, Olney J &Wheatley T. Cabergoline treatment for a large macroprolactinoma throughout pregnancy. Journal of Obstetrics and Gynaecology 1997 17 375-376.
155. Liu C & Tyrrell JB. Successful treatment of a large macroprolactinoma with cabergoline during pregnancy. Pituitary 2001 4 179-185.
156. Ricci E, Parazzini F, Motta T, Ferrari CI, Colao A, Clavenna A, Rocchi F, Gangi E, Paracchi S, Gasperi M, Lavezzari M, Nicolosi AE, Ferrero S, Landi ML, Beck-Peccoz P & Bonati M. Pregnancy outcome after cabergoline treatment in early weeks of gestation. Reproductive Toxicology 2002 16 791-793.
157. Robert E, Musatti L, Piscitelli G & Ferrari CI. Pregnancy outcome after treatment with the ergot derivative, cabergoline. Reproductive Toxicology 1996 10 333-337.
158. Verhelst J & Abs R. Hyperprolactinemia: pathophysiology and management. Treatments in Endocrinology 2003 2 23-32.
159. Laloi-Michelin M, Ciraru-Vigneron N & Meas T. Cabergoline treatment of pregnant women with macroprolactinomas. International Journal of Gynaecology and Obstetrics 2007 99 61-62.
160. Webster J. A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation. Drug Safety 1996 14 228-238.
161. Morange I, Barlier A, Pellegrini I, Brue T, Enjalbert A & Jaquet P. Prolactinomas resistant to bromocriptine long-term efficacy of quinagolide and outcome of pregnancy. European Journal of Endocrinology 1996 135 413-420.
162. Christin-Maitre S, Delemer B, Touraine P & Young J. Prolactinoma and estrogens: pregnancy, contraception and hormonal replacement therapy. Annales d'Endocrinologie 2007 68 106-112.
163. Weil C. The safety of bromocriptine in hyperprolactinaemic female infertility: a literature review. Current Medical Research and Opinion 1986 10 172-195.
164. Crosignani PG, Mattei AM, Severini V, Cavioni V, Maggioni P & Testa G. Long-term effects of time, medical treatment and pregnancy in 176
165. Rasmussen C, Bergh T, Nillius SJ & Wide L. Return of menstruation and normalization of prolactin in hyperprolactinemic women with bromocriptine-induced pregnancy. Fertility and Sterility 1985 44 31-34.
166. Bergh T, Nillius SJ & Wide L. Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumors. BMJ 1978 1 875-880.
167. Chaiamnuay S, Moster M, Katz MR & Kim YN. Successful management of a pregnant woman with a TSH secreting pituitary adenoma with surgical and medical therapy. Pituitary 2003 6 109-113.
168. Caron P, Gerbeau C, Pradayrol L, Simonetta C & Bayard F. Successful pregnancy in an infertile woman with a thyrotropinsecreting macroadenoma treated with somatostatin analog (octreotide). Journal of Clinical Endocrinology and Metabolism 1996 81 1164-1168.
169. Siristatidis C, Mastorakos G, Vitoratos N, Gregoriou O, Iakovidou H, Salamalekis E & Creatsas G. Thyroid hormone resistance and enlargement of the sella turcica during pregnancy. Archives of Gynecology and Obstetrics 2004 269 152-155.
170. Ghayuri M & Liu JH. Ovarian hyperstimulation syndrome caused by pituitary gonadotroph adenoma secreting follicle-stimulating hormone. Obstetrics and Gynecology 2007 109 547-549.
171. Murata Y, Ando H, Nagasaka T, Takahashi I, Saito K, Fukugaki H, Matsuzawa K & Mizutani S. Successful pregnancy after bromocriptine therapy in an anovulatory woman complicated with ovarian hyperstimulation caused by folliclestimulating hormone-producing plurihormonal pituitary microadenoma. Journal of Clinical Endocrinology and Metabolism 2003 88 1988-1993.
172. de Heide LJ, van Tol KM & Doorenbos B. Pituitary apoplexy presenting during pregnancy. Netherlands Journal of Medicine 2004 62 393-396.
173. Masding MG, Lees PD, Gawne-Cain ML & Sandeman DD. Visual field compression by a non-secreting pituitary tumour during pregnancy. Journal of the Royal Society of Medicine 2003 96 27-28.
174. Hayashi M, Tomobe K, Hoshimoto K & Ohkura T. Successful pregnancy following gonadotropin therapy in a patient with hypogonadotropic hypogonadism resulting from craniopharyngioma. International Journal of Clinical Practice 2002 56 149-151.
175. Aydin Y, Can SM, Gulkilik A, Turkmenoglu O, Alatli C & Ziyal I. Rapid enlargement and recurrence of a preexisting intrasellar craniopharyngioma during the course of two pregnancies. Case report. Journal of Neurosurgery 1999 91 322-324.
176. Maniker AH & Krieger AJ. Rapid recurrence of craniopharyngioma during pregnancy with recovery of vision: a case report. Surgical Oncology 1996 45 324-327.
177. Sachs BP, Smith SK, Cassar J & Van Iddekinge B. Rapid enlargement of craniopharyngioma in pregnancy. British Journal of Obstetrics and Gynaecology 1978 85 577-578.
178. Hiett AK & Barton JR. Diabetes insipidus associated with craniopharyngioma in pregnancy. Obstetrics and Gynecology 1990 76 982-984.
179. van der Wildt B, Drayer JI & Eskes TK. Diabetes insipidus in pregnancy as a first sign of a craniopharyngioma. European Journal of Obstetrics, Gynecology, and Reproductive Biology 1980 10 269-274.
180. Johnson RJ Jr, Voorhies RM, Witkin M, Robichaux AG III & Broussard WA Jr. Fertility following excision of a symptomatic craniopharyngioma during pregnancy: case report. Surgical Neurology 1993 39 257-262.
181. Feinberg EC, Molitch ME, Endres LK & Peaceman AM. The incidence of Sheehan's syndrome after obstetric hemorrhage. Fertility and Sterility 2005 84 975-979.
182. Abs R, Bengtsson BA, Hernberg-Stahl E, Monson JP, Tauber JP, Wilton P &Wuster C. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clinical Endocrinology 1999 50 703-713.
183. Engelberth O, Jezkova Z, Bleha O, Malek J & Bendl J. Autoantibodies in Sheehan's syndrome. Casopis Lekaru Ceskych 1965 104 108.
184. Goswami R, Kochupillai N, Crock PA, Jaleel A & Gupta N. Pituitary autoimmunity in patients with Sheehan's syndrome. Journal of Clinical Endocrinology and Metabolism 2002 87 4137-4141.
185. Nishiyama S, Takano T, Hidaka Y, Takada K, Iwatani Y & Amino N. A case of postpartum hypopituitarism associated with empty sella: possible relation to postpartum autoimmune hypophysitis. Endocrine Journal 1993 40 431-438.
186. Patel MC, Guneratne N, Haq N, West TE, Weetman AP & Clayton RN. Peripartum hypopituitarism and lymphocytic hypophysitis. Quarterly Journal of Medicine 1995 88 571-580.
187. Otsuka F, Kageyama J, Ogura T, Hattori T & Makino H. Sheehan's syndrome of more than 30 years' duration: an endocrine and MRI study of 6 cases. Endocrine Journal 1998 45 451-458.
188. De Bellis A, Kelestimur F, Sinisi AA, Ruocco G, Tirelli G, Battaglia M, Bellastella G, Conzo G, Tanriverdi F, Unluhizarci K, Bizzarro A & Bellastella A. Anti-hypothalamus and anti-pituitary antibodies may contribute to perpetuate the hypopituitarism in patients with Sheehan's syndrome. European Journal of Endocrinology 2008 158 147-152.
189. Bakiri F, Bendib SE, Maoui R, Bendib A & Benmiloud M. The sella turcica in Sheehan's syndrome: computerized tomographic study in 54 patients. Journal of Endocrinological Investigation 1991 14 193-196.
190. Fleckman AM, Schubart UK, Danziger A & Fleischer N. Empty sella of normal size in Sheehan's syndrome. American Journal of Medicine 1983 75 585-591.
191. Sherif IH, Vanderley CM, Beshyah S & Bosairi S. Sella size and contents in Sheehan's syndrome. Clinical Endocrinology 1989 30 613-618.
192. Tanriverdi F, Atmaca H, Durak AC, Gokce C, Unluhizarci K, Bayram F & Kelestimur F. Evaluation of the sella volume in patients with Sheehan's syndrome (Abstract), 12th International Congress of Endocrinology, Lisbon, 2004.
193. Kelestimur F. Sheehan's syndrome. Pituitary 2003 6 181-188.
194. Ozbey N, Inanc S, Aral F, Azezli A, Orhan Y, Sencer E & Molvalilar S. Clinical and laboratory evaluation of 40 patients with Sheehan's syndrome. Israel Journal of Medical Sciences 1994 30 826-829.
195. Huang YY, Ting MK, Hsu BR & Tsai JS. Demonstration of reserved anterior pituitary function among patients with amenorrhea after postpartum hemorrhage. Gynecological Endocrinology 2000 14 99-104.
196. Dokmetas HS, Kilicli F, Korkmaz S & Yonem O. Characteristic features of 20 patients with Sheehan's syndrome. Gynecological Endocrinology 2006 22 279-283.
197. Dejager S, Gerber S, Foubert L & Turpin G. Sheehan's syndrome: differential diagnosis in the acute phase. Journal of Internal Medicine 1998 244 261-266.
198. Lavallee G, Morcos R, Palardy J, Aube M & Gilbert D. MR of nonhemorrhagic postpartum pituitary apoplexy. American Journal of Neuroradiology 1995 16 1939-1941.
199. Vaphiades MS, Simmons D, Archer RL & Stringer W. Sheehan syndrome: a splinter of the mind. Survey of Ophthalmology 2003 48 230-233.
200. Haddock L, Vega LA, Aguilo F & Rodriguez O. Adrenocortical, thyroidal and human growth hormone reserve in Sheehan's syndrome. Johns Hopkins Medical Journal 1972 131 80-99.
201. Kelestimur F, Jonsson P, Molvalilar S, Gomez JM, Auernhammer CJ, ColakR,Koltowska-HaggstromM&GothMI. Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS. European Journal of Endocrinology 2005 152 581-587.
202. Kelestimur F. GH deficiency and the degree of hypopituitarism. Clinical Endocrinology 1995 42 443-444.
203. Jialal I, Naidoo C, Norman RJ, Rajput MC, Omar MA & Joubert SM. Pituitary function in Sheehan's syndrome. Obstetrics and Gynecology 1984 63 15-19.
204. Shahmanesh M, Ali Z, Pourmand M & Nourmand I. Pituitary function tests in Sheehan's syndome. Clinical Endocrinology 1980 12 303-311.
205. Kelestimur F. Sheehan's syndrome. In Growth Hormone Deficiency in Adults: 10 Years of KIMS, pp 277-287. Eds R Abs & U Feldt-Rasmussen, Oxford, UK: Oxford Pharmagenesis, 2004.
206. Kelestimur F. Hyperprolactinemia in a patient with Sheehan's syndrome. Southern Medical Journal 1992 85 1008-1010.
207. Stacpoole PW, Kandell TW & Fisher WR. Primary empty sella, hyperprolactinemia, and isolated ACTH deficiency after postpartum hemorrhage. American Journal of Medicine 1983 74 905-908.
208. Kan AK & Calligerous D. A case report of Sheehan syndrome presenting with diabetes insipidus. Australian and New Zealand Journal of Obstetrics and Gynaecology 1998 38 224-226.
209. Sheehan HL & Whitehead R. The neurohypophysis in post-partum hypopituitarism. Journal of Pathology and Bacteriology 1963 85 145-169.
210. Whitehead R. The hypothalamus in post-partum hypopituitarism. Journal of Pathology and Bacteriology 1963 86 55-67.
211. Arnaout MA & Ajlouni K. Plasma vasopressin responses in postpartum hypopituitarism: impaired response to osmotic stimuli. Acta Endocrinologica 1992 127 494-498.
212. Atmaca H, Tanriverdi F, Gokce C, Unluhizarci K & Kelestimur F. Posterior pituitary function in Sheehan's syndrome. European Journal of Endocrinology 2007 156 563-567.
213. Dash RJ, Gupta V & Suri S. Sheehan's syndrome: clinical profile, pituitary hormone responses and computed sellar tomography. Australian and New Zealand Journal of Medicine 1993 23 26-31.
214. Algun E, Ayakta H, Harman M, Topal C & Aksoy H. Spontaneous pregnancy in a patient with Sheehan's syndrome. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2003 110 242-244.
215. Chaieb L, Chadli M, Jemni L, Chatti N, Hidar M, Zebidi A & Djaidane A. Sheehan's syndrome followed by spontaneous pregnancy. Apropos of 2 cases. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction 1986 15 765-768.
216. Cohen BL & Baillie P. Sheehan's syndrome followed by successful pregnancy: a case report. South African Medical Journal 1980 57 838-840.
217. Colakoglu M, Ercal T & Karslioglu S. Commencement of normal menstrual cycles after 17 years in a patient with Sheehan's syndrome. American Journal of Medicine 1987 82 578.
218. Grimes HG & Brooks MH. Pregnancy in Sheehan's syndrome. Report of a case and review. Obstetrical and Gynecological Survey 1980 35 481-488.
219. Turksoy RN, Rogers J, Kennison RD & Finlayson WJ. Spontaneous ovulation and conception after cessation of human gonadotropin therapy in a patient with Sheehan's syndrome. Journal of Reproductive Medicine 1972 8 299-302.
220. Zargar AH, Masoodi SR, Laway BA, Sofi FA & Wani AI. Pregnancy in Sheehan's syndrome: a report of three cases. Journal of the Association of Physicians of India 1998 46 476-478.
221. Sheehan HL. Postpartum necrosis of the anterior pituitary. Effect of subsequent pregnancy. Lancet 1939 1 818-820.
222. See TT, Lee SP & Chen HF. Spontaneous pregnancy and partial recovery of pituitary function in a patient with Sheehan's syndrome. Journal of the Chinese Medical Association 2005 68 187-190.
223. Soares DV, Spina LD, de Lima Oliveira Brasil RR, Lobo PM, Salles E, Coeli CM, Conceicao FL & Vaisman M. Two years of growth hormone replacement therapy in a group of patients with Sheehan's syndrome. Pituitary 2006 9 127-135.
224. Tanriverdi F, Eryol NK, Atmaca H, Unluhizarci K, Ozdogru I, Sarikaya I, Bayram F & Kelestimur F. The effects of 12 months of growth hormone replacement therapy on cardiac autonomic tone in adults with growth hormone deficiency. Clinical Endocrinology 2005 62 706-712.
225. Tanriverdi F, Borlu M, Atmaca H, Koc CA, Unluhizarci K, Utas S & Kelestimur F. Investigation of the skin characteristics in patients with severe GH deficiency and the effects of 6 months of GH replacement therapy: a randomized placebo controlled study. Clinical Endocrinology 2006 65 579-585.
226. Ismailogullari S, Tanriverdi F, Kelestimur F & Aksu M. Sleep architecture in Sheehan's syndrome before and 6 months after growth hormone replacement therapy. Psychoneuroendocrinology 2009 34 212-219.
227. Rivera JA. Lymphocytic hypophysitis: disease spectrum and approach to diagnosis and therapy. Pituitary 2006 9 35-45.
228. Bellastella A, Bizzarro A, Coronella C, Bellastella G, Sinisi AA & De Bellis A. Lymphocytic hypophysitis: a rare or underestimated disease? European Journal of Endocrinology 2003 149 363-376.
229. Asa SL, Kelly MA, Grandy DK & Low MJ. Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice. Endocrinology 1999 140 5348-5355.
230. Baskin DS, Townsend JJ & Wilson CB. Lymphocytic adenohypophysitis of pregnancy simulating a pituitary adenoma: a distinct pathological entity. Report of two cases. Journal of Neurosurgery 1982 56 148-153.
231. Beressi N, Beressi JP, Cohen R & Modigliani E. Lymphocytic hypophysitis. A review of 145 cases. Annales de Medecine Interne 1999 150 327-341.
232. Hashimoto K, Takao T & Makino S. Lymphocytic adenohypophysitis and lymphocytic infundibuloneurohypophysitis. Endocrine Journal 1997 44 1-10.
233. Kidd D, Wilson P, Unwin B & Dorward N. Lymphocytic hypophysitis presenting early in pregnancy. Journal of Neurology 2003 250 1385-1387.
234. Ozbey N, Kahraman H, Yilmaz L, Orhan Y, Sencer E & Molvalilar S. Clinical course of a pituitary macroadenoma in the first trimester of pregnancy: probable lymphocytic hypophysitis. International Journal of Clinical Practice 1999 53 478-481.
235. Gal R, Schwartz A, Gukovsky-Oren S, Peleg D, Goldman J & Kessler E. Lymphoid hypophysitis associated with sudden maternal death: report of a case review of the literature. Obstetrical and Gynecological Survey 1986 41 619-621.
236. Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC & Rose NR. Autoimmune hypophysitis. Endocrine Reviews 2005 26 599-614.
237. Gutenberg A, Hans V, Puchner MJ, Kreutzer J, Bruck W, Caturegli P & Buchfelder M. Primary hypophysitis: clinical-pathological correlations. European Journal of Endocrinology 2006 155 101-107.
238. Elias KA & Weiner RI. Direct arterial vascularization of estrogeninduced prolactin-secreting anterior pituitary tumors. PNAS 1984 81 4549-4553.
239. O'Dwyer DT, Smith AI, Matthew ML, Andronicos NM, Ranson M, Robinson PJ & Crock PA. Identification of the 49-kDa autoantigen associated with lymphocytic hypophysitis as alpha-enolase. Journal of Clinical Endocrinology and Metabolism 2002 87 752-757.
240. O'Dwyer DT, Clifton V, Hall A, Smith R, Robinson PJ & Crock PA. Pituitary autoantibodies in lymphocytic hypophysitis target both gamma- and alpha-enolase - a link with pregnancy? Archives of Physiology and Biochemistry 2002 110 94-98.
241. Watanabe K, Tada H, Shimaoka Y, Hidaka Y, Tatsumi K, Izumi Y & Amino N. Characteristics of experimental autoimmune hypophysitis in rats: major antigens are growth hormone, thyrotropin, and luteinizing hormone in this model. Autoimmunity 2001 33 265-274.
242. Buckland RH & Popham PA. Lymphocytic hypophysitis complicated by post-partum haemorrhage. International Journal of Obstetric Anesthesia 1998 7 263-266.
243. McCutcheon IE & Oldfield EH. Lymphocytic adenohypophysitis presenting as infertility. Case report. Journal of Neurosurgery 1991 74 821-826.
244. Portocarrero CJ, Robinson AG, Taylor AL & Klein I. Lymphoid hypophysitis. An unusual cause of hyperprolactinemia and enlarged sella turcica. Journal of the American Medical Association 1981 246 1811-1812.
245. Thodou E, Asa SL, Kontogeorgos G, Kovacs K, Horvath E & Ezzat S. Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings. Journal of Clinical Endocrinology and Metabolism 1995 80 2302-2311.
246. Biswas M, Thackare H, Jones MK & Bowen-Simpkins P. Lymphocytic hypophysitis and headache in pregnancy. British Journal of Obstetrics and Gynaecology 2002 109 1184-1186.
247. Imura H, Nakao K, Shimatsu A, Ogawa Y, Sando T, Fujisawa I & Yamabe H. Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus. New England Journal of Medicine 1993 329 683-689.
248. Leggett DA, Hill PT & Anderson RJ. 'Stalkitis' in a pregnant 32-year-old woman: a rare cause of diabetes insipidus. Australasian Radiology 1999 43 104-107.
249. Leung GK, Lopes MB, Thorner MO, Vance ML & Laws ER Jr. Primary hypophysitis: a single-center experience in 16 cases. Journal of Neurosurgery 2004 101 262-271.
250. Bensing S, Hulting AL, Hoog A, Ericson K & Kampe O. Lymphocytic hypophysitis: report of two biopsy-proven cases and one suspected case with pituitary autoantibodies. Journal of Endocrinological Investigation 2007 30 153-162.
251. Karaca Z, Tanriverdi F, Donmez H, Unluhizarci K & Kelestimur F. Empty sella may be the final outcome in lymphocytic hypophysitis. Endocrine Research 2009 34 10-17.
252. Klein J & Fehm HL. Unusual presentation of hypophysitis preceding an empty sella in a 75-year-old woman. Neuroendocrinology Letters 2005 26 757-758.
253. Unluhizarci K, Bayram F, Colak R, Ozturk F, Selcuklu A, Durak AC & Kelestimur F. Distinct radiological and clinical appearance of lymphocytic hypophysitis. Journal of Clinical Endocrinology and Metabolism 2001 86 1861-1864.
254. De Marinis L, Bonadonna S, Bianchi A, Maira G & Giustina A. Primary empty sella. Journal of Clinical Endocrinology and Metabolism 2005 90 5471-5477.
255. Brandes JC & Cerletty JM. Pregnancy in lymphocytic hypophysitis: case report and review. Wisconsin Medical Journal 1989 88 29-32.
256. Gagneja H, Arafah B & Taylor HC. Histologically proven lymphocytic hypophysitis: spontaneous resolution and subsequent pregnancy. Mayo Clinic Proceedings 1999 74 150-154.
257. Sinha D, Sinha A & Pirie AM. A case of recurrent lymphocytic hypophysitis in pregnancy. Journal of Obstetrics and Gynaecology 2006 26 255-256.
258. Verdu LI, Martin-Caballero C, Garcia-Lopez G & Cueto MJ. Ovulation induction and normal pregnancy after panhypopituitarism due to lymphocytic hypophysitis. Obstetrics and Gynecology 1998 91 850-852.
259. Reusch JE, Kleinschmidt-DeMasters BK, Lillehei KO, Rappe D & Gutierrez-Hartmann A. Preoperative diagnosis of lymphocytic hypophysitis (adenohypophysitis) unresponsive to short course dexamethasone: case report. Neurosurgery 1992 30 268-272.
260. Magyar DM & Marshall JR. Pituitary tumors and pregnancy. American Journal of Obstetrics and Gynecology 1978 132 739-751.
261. van der Spuy ZM & Jacobs HS. Management of endocrine disorders in pregnancy. Part II. Pituitary, ovarian and adrenal disease. Postgraduate Medical Journal 1984 60 312-320.
262. Overton CE, Davis CJ,West C, Davies MC & Conway GS. High risk pregnancies in hypopituitary women. Human Reproduction 2002 17 1464-1467.
263. Hall R, Manski-Nankervis J, Goni N, Davies MC & Conway GS. Fertility outcomes in women with hypopituitarism. Clinical Endocrinology 2006 65 71-74.
264. Homburg R, Eshel A, Armar NA, Tucker M, Mason PW, Adams J, Kilborn J, Sutherland IA & Jacobs HS. One hundred pregnancies after treatment with pulsatile luteinising hormone releasing hormone to induce ovulation. BMJ 1989 298 809-812.
265. Tsilchorozidou T & Conway GS. Uterus size and ovarian morphology in women with isolated growth hormone deficiency, hypogonadotrophic hypogonadism and hypopituitarism. Clinical Endocrinology 2004 61 567-572.
266. de Boer JA, Schoemaker J & van der Veen EA. Impaired reproductive function in women treated for growth hormone deficiency during childhood. Clinical Endocrinology 1997 46 681-689.
267. Homburg R, Levy T & Ben Rafael Z. Adjuvant growth hormone for induction of ovulation with gonadotrophin-releasing hormone agonist and gonadotrophins in polycystic ovary syndrome: a randomized, double-blind, placebo controlled trial. Human Reproduction 1995 10 2550-2553.
268. Tarlatzis BC, Zepiridis L, Grimbizis G & Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Human Reproduction Update 2003 9 61-76.
269. Muller J, Starup J, Christiansen JS, Jorgensen JO, Juul A & Skakkebaek NE. Growth hormone treatment during pregnancy in a growth hormone-deficient woman. European Journal of Endocrinology 1995 132 727-729.
270. Curran AJ, Peacey SR & Shalet SM. Is maternal growth hormone essential for a normal pregnancy? European Journal of Endocrinology 1998 139 54-58.
271. Hall K, Enberg G, Hellem E, Lundin G, Ottosson-Seeberger A, Sara V, Trygstad O & Ofverholm U. Somatomedin levels in pregnancy: longitudinal study in healthy subjects and patients with growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 1984 59 587-594.
272. Verhaeghe J, Bougoussa M, Van Herck E, de Zegher F, Hennen G & Igout A. Placental growth hormone and IGF-I in a pregnant woman with Pit-1 deficiency. Clinical Endocrinology 2000 53 645-647.
273. Giampietro A, Milardi D, Bianchi A, Fusco A, Cimino V, Valle D, Marana R, Pontecorvi A & De Marinis L. The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature. Fertility and Sterility 2009 91 930.e7-930.e11.
274. Wiren L, Boguszewski CL & Johannsson G. Growth hormone (GH) replacement therapy in GH-deficient women during pregnancy. Clinical Endocrinology 2002 57 235-239.
275. Minneci PC, Deans KJ, Banks SM, Eichacker PQ & Natanson C. Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Annals of Internal Medicine 2004 141 47-56.
276. Suri D, Moran J, Hibbard JU, Kasza K & Weiss RE. Assessment of adrenal reserve in pregnancy: defining the normal response to the adrenocorticotropin stimulation test. Journal of Clinical Endocrinology and Metabolism 2006 91 3866-3872.
277. Diederich S, Eigendorff E, Burkhardt P, Quinkler M, Bumke-Vogt C, Rochel M, Seidelmann D, Esperling P, Oelkers W & Bahr V. 11b-Hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids. Journal of Clinical Endocrinology and Metabolism 2002 87 5695-5701.
278. Crown A & Lightman S. Why is the management of glucocorticoid deficiency still controversial: a review of the literature. Clinical Endocrinology 2005 63 483-492.
279. Arlt W & Allolio B. Adrenal insufficiency. Lancet 2003 361 1881-1893.
280. Trainer PJ. Corticosteroids and pregnancy. Seminars in Reproductive Medicine 2002 20 375-380.
281. McKenzie SA, Selley JA & Agnew JE. Secretion of prednisolone into breast milk. Archives of Disease in Childhood 1975 50 894-896.
282. LaFranchi S. Thyroid hormone in hypopituitarism, Graves' disease, congenital hypothyroidism, and maternal thyroid disease during pregnancy. Growth Hormone & IGF Research 2006 16 20-24.
283. LaFranchi SH, Haddow JE & Hollowell JG. Is thyroid inadequacy during gestation a risk factor for adverse pregnancy and developmental outcomes? Thyroid 2005 15 60-71.
284. Durr JA. Diabetes insipidus in pregnancy. American Journal of Kidney Diseases 1987 9 276-283.
285. Kallen BA, Carlsson SS & Bengtsson BK. Diabetes insipidus and use of desmopressin (Minirin) during pregnancy. European Journal of Endocrinology 1995 132 144-146.
286. Ray JG. DDAVP use during pregnancy: an analysis of its safety for mother and child. Obstetrical and Gynecological Survey 1998 53 450-455.
287. Hague WM. Pre-existing endocrine disease in relation to pregnancy. Current Obstetrics & Gynaecology 1999 9 62-68.
288. Hamai Y, Fujii T, Nishina H, Kozuma S, Yoshikawa H & Taketani Y. Differential clinical courses of pregnancies complicated by diabetes insipidus which does, or does not, pre-date the pregnancy. Human Reproduction 1997 12 1816-1818.
289. Kalelioglu I, Kubat UA, Yildirim A, Ozkan T, Gungor F & Has R. Transient gestational diabetes insipidus diagnosed in successive pregnancies: review of pathophysiology, diagnosis, treatment, and management of delivery. Pituitary 2007 10 87-93.
290. Kennedy S, Hall PM, Seymour AE & Hague WM. Transient diabetes insipidus and acute fatty liver of pregnancy. British Journal of Obstetrics and Gynaecology 1994 101 387-391.
291. Yamanaka Y, Takeuchi K, Konda E, Samoto T, Satou A, Mizudori M & Maruo T. Transient postpartum diabetes insipidus in twin pregnancy associated with HELLP syndrome. Journal of Perinatal Medicine 2002 30 273-275.
292. Campo S, Campo V & Lanzone A. Twin pregnancy using recombinant gonadotropins in a woman with hypogonadotropic hypogonadism. Gynecological Endocrinology 2002 16 27-32.
293. Dragojevic S, Pazin V, Rakic S, Nikolic B & Jovanovic T. Pregnancy using gonadotropins and performing intrauterine insemination in a woman with hypogonadotropic hypogonadism. American Journal of Reproductive Immunology 2006 55 164-167.